ARYx Therapeutics, Inc.

CIK 1410064 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ARYx Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 11, 2011SC 13G/A0001137774-11-000058
Apr 8, 201115-12B0001104659-11-019300
Mar 31, 2011NT 10-K0001104659-11-017874
Mar 29, 2011250001104659-11-017409
Mar 23, 20118-K0001104659-11-015831
Mar 21, 2011SC 13D/A0001072613-11-000329
Mar 14, 201140001181431-11-017711
Mar 14, 201140001181431-11-017713
Mar 14, 201140001181431-11-017712
Mar 14, 201140001181431-11-017710
Mar 14, 201140001181431-11-017709
Mar 11, 20118-K0001104659-11-013921
Mar 9, 20118-K0001104659-11-013320
Feb 18, 20118-K0001104659-11-008152
Feb 11, 2011SC 13G/A0000909518-11-000073
Feb 10, 2011SC 13G/A0000053417-11-000028
Feb 7, 20118-K0001104659-11-005392
Jan 31, 2011SC 13G/A0001137774-11-000008
Dec 21, 20108-K0001104659-10-063635
Dec 16, 20108-K0001104659-10-062935
Nov 26, 20108-K0001104659-10-060141
Nov 15, 20108-K0001104659-10-058404
Nov 15, 201010-Q0001104659-10-058271
Oct 21, 2010EFFECT9999999995-10-003012
Oct 12, 2010S-80001104659-10-052093